Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapeutics that take advantage of breakthroughs in science and human genetics of microglia. It harnesses the power of microglia for the treatment of neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. The company was incorporated in 2020 and is based in Cambridge, Massachusetts.
$10.81 -0.15 (-1.37%)
As of 02/03/2023 14:41:26 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.